PROTECT Cognitive Test System containing tests for memory, attention and executive function for remote, unsupervised use in clinical and research settings
Validated for sensitivity to cognitive and functional status and change with robust dementia sensitivity and correlation with p-tau217 plasma biomarker
Available as a standalone test system or for API integration
Remote Clinical Trials
Remote and hybrid clinical trial delivery through established protocols and infrastructure.
Rapid, targeted patient recruitment, high retention and over 90% data completeness.
Suitable for nutraceutical, non-pharmacological or low-risk pharmacological interventions.
Biomarker Validation
Extensive digital biomarker validation protocols including access to targeted cohort recruitment.
Biofluid biomarker studies including capillary blood biomarkers and microbiome.
Accelerated Patient Recruitment Funnel
Swift, targeted recruitment for clinical trials and pathways including screening of existing cohorts for phenotype, genotype and risk characteristics.
Leveraging consent for contact from the PROTECT-UK cohort of 30,000 patients.
Over 37,000 participants recruited to clinical trials to date.
PROTECT-UK Data Access
Access to extensive longitudinal data from the 12-year PROTECT-UK cohort of over 50,000 older adults.
Health, lifestyle, risk factor, and genetic data available for use.
Rapid review and secure data transfer.
PROTECT Team
Data analysis support.
Support throughout every project from the PROTECT team including project managers, developers, data managers, and research coordinators.
